Scinovex
article Open AccessTop 1% cited

Comorbidity and its impact on 1590 patients with COVID-19 in China: a nationwide analysis

European Respiratory Journal · 2020 · Vol. 55(5) · pp. 2000547–2000547
Wei-Jie GuanWenhua LiangYi ZhaoHeng-rui LiangZi‐Sheng ChenYimin LiXiaoqing LiuRu-chong ChenChun-li TangTao WangChun‐Quan OuLi LiPing-Yan ChenLing SangWei WangJian-fu LiCaichen LiLi-min OuBo ChengShan XiongZheng-yi NiJie XiangYu HuLei LiuHong ShanChun-liang LeiYi-xiang PengLi WeiYong LiuYa-hua HuPeng PengJian Ming WangJiyang LiuZhong ChenGang LiZhi-jian ZhengShao-qin QiuJie LuoChang-jiang YeShao-yong ZhuLin-ling ChengFeng YeShi-yue LiJin-ping ZhengNuo-fu ZhangNanshan ZhongJian-xing He

Abstract

Among laboratory confirmed cases of COVID-19, patients with any comorbidity yielded poorer clinical outcomes than those without. A greater number of comorbidities also correlated with poorer clinical outcomes.

COVID-19 Clinical Research StudiesChronic Disease Management StrategiesCOVID-19 epidemiological studiesMedicineComorbidityInternal medicineDiabetes mellitusIntensive care unitCoronavirus disease 2019 (COVID-19)PopulationCOPDHazard ratioDisease

MeSH terms

BetacoronavirusCOVID-19SARS-CoV-2AdultChinaFemaleHumansMaleMiddle AgedPneumonia, ViralPrognosisRisk FactorsComorbidityCoronavirus InfectionsPandemics

Funding

  • Guangzhou Medical University
  • Guangdong Science and Technology Department
  • Southern Medical University
  • National Health Commission of the People's Republic of China
Citations
3,762
FWCI
89.14
field-weighted impact
References
36
Percentile
100%
vs. same field & year
Citations per year
Citation Network

How this paper connects to the literature. Drag to explore, click any node to open that paper.

Comorbidity and its impact on 1590 patients with COVID-19 in China: a nationwide analysis · Scinovex